Filter by: patients
Home > Community Treatment Reports and Side Effects > Metolazone Treatment Report
What is Metolazone?

Metolazone is a diuretic that is used in the management of mild to moderate hypertension; treatment of edema in congestive heart failure and nephrotic syndrome, impaired renal function.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Other 4 0
Edema (fluid retention) 2 1 Efficacy_none
General health 1 0
Improve swallowing 1 0

See all 10 patients currently taking Metolazone

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 0
Moderate
 0
Mild
 0
None
 1

Reported Dosages

  0.5 mg daily 2.5 mg daily 5 mg daily 10 mg daily 20 mg daily 25 mg daily
  1 Number of Patients: 1 2 Number of Patients: 2 4 Number of Patients: 4 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Taking Metolazone (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work 1   Did not seem to work: 100%
Other 1   Other: 100%

See all 1 patient who’ve stopped taking Metolazone

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Metolazone

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Stopped Taking Metolazone

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Metolazone

Always
 1 100%
Usually
 0 0%
Sometimes
 0 0%
Never
 0 0%

Burden

Difficulty being on treatment

Burden of Metolazone

Very
 0 0%
Somewhat
 0 0%
A little
 0 0%
Not at all
 1 100%

Cost

Paid out of pocket

Cost of Metolazone

$200+
 0 0%
$100-199
 0 0%
$50-99
 0 0%
$25-49
 0 0%
< $25
 0 0%

See more information, including instructions, precautions, side effects, and interactions.

Report created on February 10, 2012.